FDA Inspection
Tesaro a GSK CompanyTesaro a GSK Company – FDA Inspection, May 12, 2020
Record Details
This FDA Inspection record concerns Tesaro a GSK Company, with an inspection on May 12, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Tesaro a GSK Company
- Inspection Date
- May 12, 2020
- Product Type
- Drugs
View Company Profile
ID · 714e9037-e425-43d8-b4c2-23a9380c69a5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1123818
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Tesaro a GSK Company
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 20, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 1, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Tesaro a GSK Company
- FDA Inspection 1101895 - 2019-07-16
- FDA Inspection 999778 - 2017-01-20
- FDA Inspection 924618 - 2015-04-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.